The aim of the thisstudy was to investigate the ozone dosage required to remove active pharmaceutical ingredients (APIs) from biologically treated wastewater of varying quality, originated from different raw wastewater and wastewater treatment processes. Secondary effluents from six Swedish wastewater treatment plants (WWTP) were spiked with 42 APIs (nominal concentration 1μg/L) and treated with different O 3 doses (0.5-12.0 mg/L ozone) in bench-scale experiments.
Introduction
The modern life-style of developed countries involves daily usage of artificial compounds such as active pharmaceutical ingredients (API), personal care products, hormones, pesticides and other environmentally persistent chemicals. As a result residues of these compounds become micropollutants in wastewater Hollender et al., 2009; Richardson, 2010; Gerrity and Snyder, 2011; Huber et al., 2005; Richardson, 2010) . Of all groups of micropollutants the vast majority of research activities are currently focused on the fate of active pharmaceutical ingredients during wastewater treatments (Hollender et al., 2009; Huber et al., 2003; Huber et al., 2005; Lee and von Gunten, 2010; Zimmermann et al., 2011; Fick et al., 2011; Falås et al., 2012a Falås et al., , 2012b . APIs by purpose are generally designed to illicit a specific biological action. Due to their use pattern, release to the environment is mainly via sewage outlets into surface waters. APIs are usually found at concentrations ranging from pg/L-μg/L in wastewater and surface waters influenced by wastewater outlets. However, chronic exposure of APIs to humans and wildlife even at these low concentrations is both of scientific and societal concern (Richardson, 2010).
To address this problem many WWTPs consider incorporating an additional treatment process step to remove APIs from the effluent. Treatment with O 3 appears to be one of the most promising technologies for the removal of these compounds (Ternes et al., 2003 . Hansen et al., 2010 Hollender et al., 2009; Huber et al., 2003; Huber et al., 2005; Lee and von Gunten, 2010; Zimmermann et al., 2011) .
One of the first studies which showed the efficiency of ozonation for removal of micropollutants in biological treated wastewater was by Ternes et al. (2003) . Ozonation was employed at 5.0 to 15.0 mg/L of O 3 to investigate the removal efficiency (Ternes et al., 2003) for selected APIs, personal care products and iodated X-ray contrast media. Pharmaceuticals and personal care products were removed sufficiently by only 5 mg/L of O 3 while the iodated X-ray contrast media were only partially removed by 15 mg/L of O 3 . However, as there is not much toxicological concern for iodated X-ray contrast media results were interpreted as promising and more optimised treatment studies were conducted which reported efficient removal of pharmaceuticals and hormones in wastewater at lower O 3 doses (2.0-3.5 mg/L) (Bahr et al., 2007; Hansen et al., 2010; Huber et al., 2005) . Estimating the removal efficiencies of APIs from wastewater effluents in bench and pilot scale experiments, was the main focus of subsequent studies (Hollender et al., 2009; Huber et al., 2003; Zimmermann et al., 2011) . For example, Hollender et al. (2009) studied the removal efficiencies of 220 pharmaceuticals in full scale with conventional activated sludge sewage treatment followed by ozonation and sand filtration. Kinetic studies and modeling of ozonation based on reactor hydraulics, O 3 chemistry and reaction kinetics were also performed for a full scale municipal wastewater facility (Zimmermann et al., 2011) .
Generally, APIs and other micropollutants are easy to degrade, i.e. can be removed with low ozone dosage, if they react reasonable fast with molecular ozone. If a micropollutant does not react well with ozone it will still degrade with higher applied ozone dosage via a secondary oxidation mechanism by which O 3 in water is converted to the hydroxyl radical, HO  , which is very reactive (non-selective) to most organic molecules.
Up to now, the parameter most commonly used by researchers to determine how well an API reacts with O 3, is the second order rate constant with O 3 (k O3,API , selective oxidation) and HO  (k HO,API , non-selective oxidation) (Hollender et al., 2009; Huber et al., 2003; Zimmermann et al., 2011) . According to these studies, compounds with k O3,API greater than 10 4 M -1 s -1 , require low delivered O 3 doses (easily degraded). Compounds with k O3,API < 10 4 M -1 s -1 , are more persistent to O 3 treatment and therefore their degradation occurs mainly via reaction with HO  , the secondary degradation route of ozonation.
However, of the several hundred APIs which have been detected in WWTP effluents (Ternes et al., 1998; Kolpin et al., 2002; Hollender et al., 2009; Fick et al., 2011; Falås et al., 2012) very few have had their respective k O3,API and k HO,API determined (Benner and Ternes, 2009; Buffle et al., 2006a; Dodd et al., 2006; Huber et al., 2003; Huerta-Fontela et al., 2011) .
In fact, constants are available for less than 10% of the model APIs used in this study (Table   S2 ). Even when these two rate constants (k O3,API and k HO,API ) are known for an API, an experiment to determine the ozone and HO exposure that results from an ozone dose in the specific wastewater is needed before the degradation of the API can be predicted (Huber et al., 2005; Buffle et al., 2006b) .
With O 3 production being an energy intensive process (Kim and Tanaka, 2011) , it is important for WWTPs to use optimum O 3 doses that achieve sufficient API degradation while maintaining low operational cost (Bahr et al., 2007; Hansen et al., 2010) . APIs exhibit different susceptibilities to O 3 degradation which can vary up to 10 orders of magnitude (Hoigne and Bader, 1983; Hollender et al., 2009; Huber et al., 2003) . They are also competing for O 3 degradation with the organic components found in the matrix of the WWTP effluent (Hollender et al., 2009 ) that vary in amount and quality depending on the treatment process and origin of wastewater. This makes it particularly difficult to predict the required O 3 dosage requirements (DO 3 ) for satisfactory API removal in WWTP effluents, which is a crucial parameter in estimating treatment design and therefore cost.
Therefore, this study aimed to unveil a more direct approach to describe the removal of pharmaceuticals in wastewater effluents, which could also be used to predict the required O 3 dose for 90% removal of a specific pharmaceutical in a wastewater, solonly based on simple water quality parameters. To achieve this, the required delivered O 3 dose (0.5 mg/L ≤ DO 3 ≤ ~12 mg/L) to achieve one order of magnitude removal of 42 APIs (at low concentrations, μg/L, Table S2 ) from 6 Swedish WWTP effluents, were investigated. These APIs are commonly found in the WWTP effluents of Sweden (Fick et al., , 2012 Falås et al., 2012a) and have different susceptibilities to ozonation (Benner and Ternes, 2009; Buffle et al., 2006a; Dodd et al., 2006; Hoigne and Bader, 1983; Huber et al., 2003) .
Effluents used in the experiments were chosen to represent typical variations observed in the main traditional characteristics of effluent quality that would occur due to different treatment processes currently employed in Sweden and also variability in raw water, i.e. COD, alkalinity and N-NH 4 + content (Table 1) .
As API's begin to react with O 3 , they are also competing with the matrix components of the effluent for O 3 degradation, therefore this study attempted to correlate the DO 3 with the effluent characteristics.
Materials and Methods

Chemicals
All pharmaceutical reference standards were of analytical grade (>98%) purchased from different suppliers (Table S3 ). A stock solution of the APIs was prepared in methanol (Merck, Darmstadt, Germany) at concentration of about 100 mg/L. The experimental set-up for the ozonation was based on a 1.0 g/h ozone generator from O 3 -Technology AB,Vellinge, Sweden, which was supplied with dry oxygen gas. The generated O 3 was dispersed though a diffuser in a collection bottle containing Milli-Q water. The later one was immersed in an icebath sot that O 3 solubility is increased. Based on these experimental conditions, the concentration of O 3 in the stock solution was between 30 and 40 mg/L. Further details are found in Antoniou and Andersen (2012) .
Wastewater effluents
Effluents from five WWTPs in Sweden, including Källby (Effluent 1&2), Björnstorp (Effluent 3), Oresundsverket (Effluent 4), Sjölunda (Effluent 5), and Nykvarnsverket (Effluent 6) were used in this study. Effluent 1 and Effluent 2 were from the same treatment plant but were collected on separate occasions with a 3 week time interval. Although Effluent 1 and Effluent 2 come from the same WWTP, they were treated as 2 different effluents due to the variability of their characteristics. This difference is attributed to the significant rainfall events which occurred following the first sampling event. Continues rainfall most likely caused a sludge wash-out, reducing the biological treatment efficiency and increasing the COD value, while at the same time alkalinity value reduced because of dilution with the rain water. The characteristics and treatment processes that are performed at each WWTP are listed in Table 1 and extensively described in S.I., respectively. As nitrification was well functioning in all WWTPs, the measured concentration of nitrite in the effluents was below 0.1 mg/L. 
Data treatment
In order to determine the O 3 dose that achieved 90% removal of each API in every effluent, the removal rate achieved with each O 3 dose in each effluent were fitted with Equation 1.
Equation 1 is an exponential formula that describes the remaining API concentration in relation to its initial concentration after a specific O 3 dose is delivered (DO 3 ). It is dependent on the fact that ozone's fate in the effluent is determined by the effluent's matrix and not significantly affected by the reaction with the APIs; therefore is independent from the APIs 
Equation 1 resembles the general formula used for the characterization of the effectiveness of energy intensive advanced treatment methods (Equation 2) recommended by IUPAC and described by Bolton et al. (2001) . Equation 2 correlates the electrical energy dose (EED) with the residual concentration of the treatment target compound and uses the constant E EO which is the EED required to achieve 90% removal (Bolton et al., 2001) .
was suggested by Hansen et al., (2010) who used both Equations 1 and 2 to describe the effectiveness of O 3 treatment for estrogenic chemicals in WWTP effluents in terms of the O 3 and energy dosage applied. Based on the above, it was decided to use the same system of equations to describe the effectiveness of O 3 -treatment for API removal from wastewater. Data treatment (determination of DDO 3 ) was conducted in GraphPad Prism 5.
Results and Discussion
Removal of APIs from 6 WWTP effluents: Effect of wastewater matrix
In this study, 42 APIs commonly found in WWTP effluents in Sweden were spiked in six different WWTP effluents and treated with O 3 to evaluate their removal efficiencies and the effect of the matrix. Figure 1 Overall, all APIs in Effluents 2, 3, and 6 were removed by over 50% at the highest O 3 dosage. In Effluents 1 and 4, only 1 API had less than 50% removal, while 7 APIs were poorly removed (< 50%) in Effluent 5 even at the highest O 3 dosage.
Based on the results shown in Figure 1 , an APIs' susceptibility to O 3 degradation appears to be highly dependent on the type of wastewater used, explaining the wide range of removal efficiencies that some APIs exhibited in this study. Specifically, the synthetic steroid beclomethasone was removed between 0-98% in the 6 effluents. Removal of fluconazole (antifungal) and flutamide (antiandrogen) ranged between 33-77% and 13-87%, respectively, inferring that some APIs were not effectively degraded (to reach the treatment goal of 90%)
in any of the tested-effluents with the applied O 3 doses. 
Required ozone dose to achieve 90% removal of API in WWTP effluents
In order to determine the O 3 dosage that achieving 90% removal of each API in every effluent, the data shown on Figure 1 were fitted with Equation 1. For each API and effluent there are 3 results of each O 3 dose applied that stems from the triplicate O 3 addition which are fitted as independant points. Selected fitting curves are shown in Figure 2 and all the curves for the 42 APIs in the 6 effluents are shown in Figures S1-S6 .
In this study, at lower O 3 doses an apparent lag-phase towards degradation was observed for some APIs and it wasn't until higher O 3 doses were applied that degradation occurred ( Figure 2B ). Once the O 3 lag-phase dose was surpassed, a decrease of APIs concentrations was observed as DO 3 increased which is similar to the curve shape (exponential decay) for APIs which did not show this lagphase. It is our belief, that the lag-phase is a result of the Figure   S7 for graphical representation). 
The resulting estimated DDO 3 values of each API in all the effluents are presented in Table 2 . Significant variation is observed in the DDO 3 values of a specific API depending on the wastewater effluent matrix. For example, carbamazepine exhibited a low DDO 3 of ~2 mg/L in Effluent 3, compared to the high DDO 3 of ~ 10 mg/L in Effluent 5. This confirms the strong influence exerted by the wastewater matrix components on APIs removal efficiencies with O 3 . This has also been observed by Benitez et al. (2009) during O 3 -treatment of pharmaceuticals (including metoprolol and naproxen) in surface and ground water and wastewater. Their results showed higher pharmaceutical removal in surface water (alkalinity=30 mg CaCO 3 /L) compared to groundwater (alkalinity=388 mg CaCO 3 /L), while the effluent containing the lowest DOC and alkalinity had the highest removal among the 3 secondary effluents tested (Benitez et al., 2009 Bahr et al., 2010. In comparison, our work showed the dosage of ozone required for 90 % removal to be 1.61 and 1.51 g O 3 /g DOC, respectively, for these two APIs.
The degradation profiles of select APIs in the 6 effluents that follow first order decay with the added O 3 (carbamazepine, naproxen) are shown in Figure 2A while Figure 2B depicts the degradation profiles of the APIs that exhibited an apparent lag phase before any significant degradation occurred (beclomethasone, memantine). Intersection of the horizontal line with the y-axis in Figures 2 and S1-S6 indicates the DDO 3 of the APIs from which it is evident that Effluent 5 is the most recalcitrant to O 3 -treatment as it requires the higher DDO 3 for all APIs compared to the other effluents (Figures 2A and 2B ).
Based on the data shown in 
Effect of chemical structure of APIs on O 3 reactivity
The chemical structure of each API and the functional groups comprising it determine whether an API would be easy or difficult to degrade with O 3 . Due to its electronic configuration, O 3 can perform different types of reactions in water including oxidation reactions, cycloadditions and electrophilic substitution reactions (Beltrán, 2004) . Easily degradable APIs (relatively low [DDO 3 /DOC] values) are characterized by the presence of electron-rich functional groups and they mainly react readily with O 3 through electrophilic substitution. These functional groups include C=C double bonds (found in eprosartan, carbamazepine), tertiary amines (repaglinide, clomipramine), aniline (dicofenac), phenol (iezetimibe) and methoxy groups (trimethoprim, diltiazem, naproxen) (Hoigne and Bader, 1976; Huber et al., 2003; Huber et al., 2005; Nakada et al., 2007 , Hollender et al., 2009 ).
APIs which are poorly removed (relatively high [DDO 3 /DOC] values) generally contain electron-withdrawing functional groups, such as fluoro (flutamide, fluconazole), nitro (flutamide), chloro (beclomethasone), amide (flutamide) and carboxyl (ibuprofen, ketoprofen) (Hey et al., 2012; Nakada et al., 2007; Acero et al., 2000; Hollender et al., 2011) .
Electron withdrawing groups reduce edensity from the APIs structure inhibiting electrophilic substitution reactions from occurring. In addition, the electronegative groups themselves are less likely to react with O 3 and thus cause a shielding effect.
Some easily degradable APIs such as carbamazepine and diclofenac also contain electron-withdrawing functional groups (amide in carbamazepine, chloro and carboxylic acid in diclofenac) but remain O 3 -reactive, inferring the presence and position of the high edensity functional groups, such as the aromatic amine (diclofenac) and C=C double bond (carbamazepine) (Nakada et al., 2007) , counteracts the inhibitory effect .
Ibuprofen possesses no electron-rich functional group and is recalcitrant towards O 3treatment (Huber et al., 2005) however can be adequately removed through intense biological treatment (e.g. Falås et al., 2012a Falås et al., , 2012b ). In addition, effective oxidative removal of O 3 -resistant APIs may be possible through the hydroxyl radical pathway (Antoniou et al., 2008) .
Conclusions
 When the effect of O 3 dose on degradation of 42 APIs in 6 different WWTP effluents was investigated, a large variability between APIs and effluents types was observed.
 The estimated DDO 3 of a specific API, used to evaluate the necessary O 3 dose to achieve reduction by one decade, varied significantly among the effluents investigated.
 DDO 3 was correlated with the effluent DOC by calculating the DDO 3 /DOC for each API in every effluent. This enabled ranking of the different APIs into easily degradable, moderately degradable and recalcitrant to O 3 -treatment categories.
 Following this practice, the required O 3 dose can be predicted based on the target pharmaceutical and the matrix component of the wastewater (DOC) to be treated.
 An O 3 dose of 1.4 g per g DOC removed (by at least 90%) more than 80% of the APIs tested in this study. To remove the most O 3 -recalcitrant APIs a dose in the order of 2.4 g O 3 per g DOC is required.
